We recently reported evidence for differential regulation of the translation machinery during human myeloid differentiation, specific to the monocytic/macrophage pathway or to the granulocytic pathway. A decrease in translation rates and concomitant regulation of two repressors of translation initiation, 4E-BP1 and 4E-BP2 (elF4E-binding proteins 1 and 2), occur in cells induced to differentiate along the monocytic/macrophage pathway or along the granulocytic pathway. Induction of HL-60 and U-937 cell differentiation into monocytes/macrophages results in a dephosphorylation and consequent activation of 4E-BP1. In contrast, following treatment of HL-60 cells with retinoic acid (RA) which results in a granulocytic differentiation of these cells, 4E-BP1 protein expression is decreased whereas 4E-BP2 protein expression is strongly increased. In this study, we further investigated the regulation of 4E-BP1 and 4E-BP2 in the RA-induced differentiation process using the NB4 promyelocytic cell line and the RA maturation-resistant NB4 subclones, NB4-R1 and NB4-R2. RA treatment resulted in a decrease in 4E-BP1 protein and mRNA expression and concomitant increase in 4E-BP2 protein expression, in NB4 cells, but not in NB4-R1 and NB4-R2 cells. The increase in 4E-BP2 protein expression was not correlated to an increase in 4E-BP2 mRNA level suggesting a post-transcriptional regulation of 4E-BP2 expression. In RA-primed cells, cAMP induce maturation of NB4-R1, but not NB4-R2 cells. cAMP treatment resulted in a down-regulation of 4E-BP1 protein and mRNA expression in RA-primed NB4-R1, but not NB4-R2 cells. However, 4E-BP2 expression was not modified in both cell types following cAMP treatment. This indicates that 4E-BP1 down-regulation is associated with granulocytic maturation, whereas post-transcriptional regulation of 4E-BP2 expression is associated with the early action of RA. Leukemia (2000Leukemia ( ) 14, 1909Leukemia ( -1914 
Introduction
Control of gene expression at the translational level is an important determinant of cell growth and differentiation. The initiation phase is rate limiting for the overall process (reviewed in Refs 1 and 2). This step entails the process leading to the positioning of the ribosome at the mRNA AUG initiation codon. Ribosome binding is mediated by the multisubunit translation initiation factor elF4F, which binds to the cap structure present at the 5Ј end of most eukaryotic cellular mRNAs. 3, 4 elF4F is composed of three subunits: elF4E, the cap-binding protein; elF4A, an RNA helicase and elF4G, responsible for the proper folding of the complex. Two repressors of cap-mediated translation, termed 4E-BP1 and 4E-BP2 (elF4E binding proteins-1 and -2) have been characterized. [5] [6] [7] 4E-BP1 and 4E-BP2 share 56% identity and specifically inhibit cap-dependent translation, both in vivo and in vitro. 4E-BP1 and 4E-BP2 are negative regulators of cell growth 8 and 4E-BP1 phosphorylation is rapamycin-sensitive. 9 In addition, we have reported that expression of 4E-BP2, high in human immature thymocytes, is down-regulated during thymocyte maturation. 10 Recently, we demonstrated that retinoic acid (RA) treatment of an human leukemia cell line, HL-60, results in a decrease of 4E-BP1 expression and a strong induction of 4E-BP2 protein expression.
11 All-trans retinoic acid is a natural and biologically active metabolite of vitamin A, which modifies gene expression by binding to its specific nuclear receptor. Retinoids induce acute promyelocytic leukemia (APL) differentiation, [12] [13] [14] and numerous studies have focused on the effects of this drug on leukemia. As the M2 type HL-60 cell line, the M3 type NB4 cell line, a t(15;17) acute promyelocytic leukemia cell line, is induced to mature into granulocytes in vitro by RA. 15 APL is characterized by a development arrest of granulopoiesis at the promyelocytic stage. Two NB4-derived maturation-resistant cell lines have been generated, NB4-R1 and NB4-R2. 16, 17 NB4-R1 respond to RA and become competent for maturation, but maturation triggering requires a cAMPdependent event. No such co-operation is observed in the R2 resistant cells. Therefore, NB4, NB4-R1 and NB4-R2 cells provide useful experimental models to study the role of 4E-BP1 and 4E-BP2 expression during granulopoiesis and their potential implication in the mechanisms responsible for RA maturation resistance.
Materials and methods

Cell lines and reagents
The human promyelocytic cell line NB4, and the two sublines resistant to RA-induced maturation, NB4-R1 and NB4-R2, were kindly provided by Dr Lanotte (INSERM U-496, Hô pital St Louis, Paris, France). [15] [16] [17] These cell lines were grown in the presence of 5% heat-inactivated FCS, using RPMI-1640 medium supplemented with 2 mM L-glutamine, 10 mM Hepes buffer, and gentamycin (20 g/ml). All-trans retinoic acid (RA) was kindly provided by Hoffman-La Roche (Basel, Switzerland). 8-Chlorophenylthio-cAMP (8-CPT-cAMP) was purchased from Sigma-Aldrich (St-Quentin-Fallavier, France). RA and 8-CPT-cAMP were dissolved in absolute ethanol and in RPMI-1640 respectively, at an initial concentration of 10 −2 M. Dilutions were performed in RPMI-1640 medium. The final concentration of ethanol had no effect on cell growth and differentiation. RPMI and fetal calf serum (FCS) were supplied by Life Technologies (Sarl, France).
Metabolic labelling
Untreated and treated NB4, NB4-R1 and NB4-R2 cells were preincubated for 1 h in methionine-free RPMI 1640
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S-methionine (100 Ci) was added for 4 h, and cells were lysed in 20 mM Tris-HCl, pH 7.5 buffer containing 5 mM EDTA and 100 mM KCl. The radioactivity incorporated into trichloro-acetic acid precipitable material was measured.
SDS-PAGE and Western blotting
Cells were rinced twice with ice cold PBS and lysed by successive freeze-thaw cycles, in 20 mM Tris-HCl, pH 7.5 buffer containing 5 mM EDTA and 100 mM KCl. The homogenate was centrifugated at 6000 g for 10 min and the supernatant was collected. To analyse for 4E-BP1 and 4E-BP2, 100 g of protein was loaded on to a 15% polyacrylamide gel. Proteins were transferred on to a 0.22 m nitrocellulose membrane (Schleicher and Schuel, Dassel, Germany), which was blocked in 5% milk for 2 h followed by incubation for 2 h with rabbit polyclonal antisera against 4E-BP1 (11208), 4E-BP2 (11211) and actin (ICN Biomedicals, Aurora, OH, USA) in 10 mM Tris-HCl, pH 8 buffer containing 150 mM NaCl at a dilution 1:1000. The membrane was then incubated for 2 h with HRP-labeled conjugate antibody at a 1:2000 dilution. Immunodetection was realized by ECL reagents.
RNA extraction and Northern blot
Total RNA was extracted from untreated and treated NB4, NB4-R1 and NB4-R2 cells by guanidium isothiocyanate lysis and CsCl centrifugation and separated by electrophoresis through 1% agarose, 6% formaldehyde gels. Twenty micrograms of denaturated total RNA were used for each lane. After transfer on to nylon membrane, RNA blots were UVcross-linked (UV Stratalinker, 120 000 J, Stratagene, La Jolla, CA, USA), prehybridized in 50% formamide, 5 × SSPE, 1 × Denhardt's solution and 0.5% sodium dodecyl sulfate (SDS) for 24 h at 42°C, and then hybridized for 24 h at 42°C in the same solution containing 200 g/ml of heat-denatured salmon sperm DNA and 32 P-labeled cDNA probe (adding approximatively 2 × 10 6 c.p.m. of the labeled probe/ml). Following washes of increasing stringency, membranes were analyzed with a Phosphorlmager (Molecular Dynamics, Sunnyvale, CA, USA). The blots were rehybridized with an actin probe to ensure that equal amounts of RNA were present in each lane. The 4E-BP1 and 4E-BP2 probes were a 0.8 kb human 4E-BP1 and a 3.5 kb human 4E-BP2 cDNA fragment. The control probe was an actin probe made of a 2.1 kb human cDNA fragment. For Northern blot analysis, cDNA inserts were purified and labeled with 32 P-dCTP using a random primer kit (Multiprime labeling kit; Amersham, Buckingham, UK) according to the manufacturer's instructions.
Results
Protein synthesis rates in RA-treated NB4, NB4-R1 and NB4-R2 cells
We previously reported that granulocytic differentiation of HL-60 cells following RA treatment is accompanied by an inhibition of translation rates and by specific modulation of the translation repressors, 4E-BP1 and 4E-BP2. 11 We wished to determine if such effects were also observed in NB4 cells and if they were altered in the RA-resistant cells. The maturationsensitive NB4 and the -resistant NB4-R1 and NB4-R2 cells were treated with RA (1 M) for 3 and 5 days and to assess their differentiation stage, morphology of the cells was analyzed by the method of May-Grü nwald staining (data not shown). NB4 cells treated with RA acquired granulocytic morphology, with chromatin condensation, loss of nucleoli, and nuclear lobulation, whereas NB4-R1 and NB4-R2 cells did not respond to RA and maintained their blastic morphology (data not shown). We measured protein synthesis rates during differentiation of the NB4, NB4-R1 and NB4-R2 cells (Figure 1 ). The translation rate was determined by metabolic labelling of cells with 35 S-methionine. Protein synthesis was strongly inhibited in NB4 cells induced to differentiate into granulocytes in response to RA for 5 days (85% inhibition). However, no significant reduction of protein synthesis was observed in RA-treated NB4-R1 and NB4-R2 cell lines. In contrast, a slight increase of protein synthesis rate was observed in the NB4-R2 cells, after 5 days of RA treatment.
Expression of 4E-BP1 and 4E-BP2 during RA treatment of NB4, NB4-R1 and NB4-R2 cells
In order to study the effect of RA on 4E-BP1 and 4E-BP2 expression, NB4, NB4-R1 and NB4-R2 cells were treated for 3 and 5 days with 1 M of RA, and total cell extracts were analyzed by Western blotting. Several isoforms of 4E-BP1 (indicated by the arrows; Figure 2 ) were detected following immunoblotting using a specific antibody against 4E-BP1. We previously reported that these isoforms represent various phosphorylation states of 4E-BP1, the fastest migrating electrophoretic isoform corresponding to the unphosphorylated 4E-BP1. 5, 6, 9 It should be noted that basal expression of
Figure 1
Protein synthesis rates in response to RA. NB4, NB4-R1 and NB4-R2 cells (10 5 /ml) were cultured for 3 days without or with 1 M of RA. 10 6 cells were preincubated for 1 h in methionine-free medium, the 35 S-methionine (100 Ci) were added for 4 h, and radioactivity incorporated into TCA-precipitable material was measured. The effects of RA are expressed as percent of the control untreated cells. The experiment was carried out three times and the error bars indicate the standard deviation from the mean.
Figure 2
Western blot analysis of 4E-BP1 and 4E-BP2 protein levels in RA-treated NB4, NB4-R1 and NB4-R2 cells. Cells were seeded at an initial density of 10 5 cells/ml in medium without (−) or with (+) 1 M of RA. At 3 (a) and 5 (b) days of culture, cells were lysed and total protein extracts were analyzed by Western blotting, using rabbit anti-4E-BP1 (1:1000), rabbit anti-4E-BP2 (1:1000) and monoclonal anti-actin (1:5000) antibodies.
4E-BP1 and 4E-BP2 was lower in NB4-R1 as compared to NB4 and NB4-R2 cells (Figure 2 ). Consistent with our previous observations on HL-60 cells, 11 differentiation of NB4 cells into granulocytes resulted in a decrease in 4E-BP1 protein expression by three-fold after 3 days of RA treatment (Figure 2a) , and 4E-BP1 was barely detectable after 5 days of treatment (Figure 2b ). In addition, RA treatment for 3 or 5 days resulted in a strong induction of 4E-BP2 protein expression (five-to six-fold). In contrast, expression of either 4E-BP1 or 4E-BP2 remained unchanged in NB4-R1 and NB4-R2 cells treated by RA for up to 5 days. Kinetics of induction by RA of 4E-BPs expression in NB4 cells were determined (Figure 3 ). 4E-BP1 down-regulation was observed after a 48-h incubation period with RA, whereas maximal 4E-BP2 up-regulation was observed as early as 16 h of RA treatment, and remained upregulated during terminal maturation. Therefore, NB4 and NB4 resistant cells responded differently to all-trans RA treatment with respect to 4E-BP1 and 4E-BP2 regulation. 4E-BPs proteins were not affected in the two resistant cell, whereas a decrease of 4E-BP1 and a concomitant increase of 4E-BP2 was observed in the parental cell line.
We performed Northern blotting analysis to examine 4E-BP1 and 4E-BP2 mRNA expression in the NB4 cell lines. Exposure to RA for 3 days resulted in a strong decrease in 4E-BP1 mRNA (0.8 kb) whereas no modification of 4E-BP2 mRNA (3.5 kb) level was detected as quantified by densitome-
Figure 3
Kinetics of 4E-BP1 and 4E-BP2 expression during RA treatment of NB4 cells. At various time periods from 0 to 48 h of 1 M RA treatment, cells were lysed and total protein extracts were analyzed by Western blotting using anti-4E-BP1, 4E-BP2 and actin antibodies.
Leukemia try (Figure 4 ). 4E-BP1 and 4E-BP2 mRNAs levels remained unchanged in both resistant cell lines treated by RA for 3 days. These results suggest that the regulation of 4E-BP1 expression is controlled primarily at a transcriptional level, whereas 4E-BP2 expression is regulated at a post-transcriptional level, and that these regulations are defective in RA-resistant cells. Similar observations were obtained in HL-60 cells induced to differentiate into granulocytes by RA.
11
Effect of cAMP on protein synthesis, 4E-BP1 and 4E-BP2 expression in NB4-R1 and NB4-R2 cells, pretreated with RA
Previous work has shown that it is possible to reverse the NB4-R1 resistance to terminal differentiation into granulocytic cells.
17 NB4-R1 cells respond to RA, but fail to mature unless the 'priming' signal is complemented by cAMP. When grown for 3 days in a combination of 100 M of 8-CPT-cAMP, a stable agonistic cAMP analog, and 1 M of RA, RA-primed NB4-R1 cells became significantly larger and presented lobed or multiple nuclei and loss of basophilic cytoplasm (data not shown). NB4-R2 cells morphology did not change upon treatment with 8-CPT-cAMP. We therefore investigated if 8-CPTcAMP affected protein synthesis in NB4-R1 cells primed by RA. We determined protein synthesis rates in NB4-R1 and
Figure 4
Northern blot analysis of 4E-BP1 and 4E-BP2 mRNAs during RA treatment of NB4, NB4-R1 and NB4-R2 cells. Cells were cultured for 3 days with medium alone (−) or with 1 M of RA (+). Total cellular RNA (20 g/lane) was separated on formaldehyde-agarose gels, transferred to nitrocellulose, and hybridized to the designated cDNA probes. The same filter was subsequently hybridized with the actin probe to control the amounts of RNA loaded in each lane. The amount of 4E-BP1 and 4E-BP2 mRNA was analyzed by phosphorimager. The values are standardized with respect to the actin mRNA level.
NB4-R2 cells pretreated by RA over 7 days and then treated with RA alone (1 M) or with a combination of RA and 8-CPTcAMP (100 M). Following RA plus 8-CPT-cAMP treatment, a rapid decrease in protein synthesis rates, approximately fivefold control level, was observed in the NB4-R1 cell line, whereas protein synthesis rates in the NB4-R2 cell line remained unchanged (Figure 5a) . Thus, as in NB4 cells, terminal maturation of NB4-R1 cells is accompanied by an inhibition of protein synthesis.
In order to determine if the terminal maturation of NB4-R1 which correlates with an inhibition of protein synthesis is accompanied by a specific modulation of 4E-BP1 and 4E-BP2, we analyzed by Western blot the expression of both proteins in NB4-R1 and NB4-R2 cells, pretreated with RA. Granulocytic maturation of NB4-R1 cells primed by RA and triggered by cAMP resulted in a strong diminution of 4E-BP1 expression leading to an undetectable expression of 4E-BP1 (Figure 5b) . However, in contrast to our observations in the NB4 parental cell line, 4E-BP2 protein expression remained unchanged in NB4-R1 RA-primed and cAMP-triggered cells. Therefore, despite maturation of the cells, RA plus cAMP failed to restore the increase of 4E-BP2 observed during terminal differentiation of the NB4 parental cell line. Western blot analysis of RA-pretreated and cAMP-treated NB4-R2 cells revealed no variation in 4E-BP1 and 4E-BP2 protein expression consistent with the resistance status of these cells.
By Northern blot analysis, we observed a reduced 4E-BP1 mRNA level in both NB4 and NB4-R1 cells induced to granulocytic maturation (Figure 5c ). Note that in NB4 cells, complete cell maturation achieved by a RA and cAMP combination revealed a stronger decrease in 4E-BP1 mRNA than observed during maturation of these cells induced by RA alone. No modification in 4E-BP2 mRNA level was observed in all three cell lines (data not shown).
Discussion
There is considerable flexibility in the myeloid differentiation program and the biological functions of the cells depend on the successful completion of the differentiation pathway from immature precursor cells to the mature cells. Control of gene expression can result in expression of specific cell functions. The acute promyelocytic leukemia (APL) with t(15;17) rearrangement responds to the differentiation agent all-trans RA with complete but not durable remissions. To identify mechanisms responsible for RA resistance in APL, RA maturation-resistant NB4 cell lines were derived from parental NB4 cells. 16, 17 Our results show that during RA-induced maturation of NB4 cells along the granulocytic pathway, expression of the translation inhibitors 4E-BP1 and 4E-BP2 is respectively down-and up-regulated. Regulation of 4E-BP1 and 4E-BP2 expression may be responsible at least in part for the reduction in protein synthesis we observed during maturation of these S-methionine (100 Ci) were then added for 4 h, and radioactivity incorporated into TCA-precipitable material was measured. The effects of the different agents are expressed as percent of the control. The experiment was carried out three times and the error bars indicate the standard deviation from the mean. (b) Effect on 4E-BP1 and 4E-BP2 protein expression. Total protein extracts were analyzed by Western blotting using anti-4E-BP1, -4E-BP2 and -actin antibodies. (c) Effect on 4E-BP1 mRNA level. Total cellular RNA (20 g/lane) was electrophoresed, transferred on nitrocellulose membrane, and hybridized with cDNA probe specific for 4E-BP1 mRNA. The amount of 4E-BP1 was analyzed by phosphorimager. An actin cDNA probe was used to calibrate the gel RNA loads and to standardize the values of 4E-BP1 mRNA.
cells. Up-regulation of 4E-BP2 during granulocyte differentiation is an early event as it occurs after 16 h of RA treatment and involves post-transcriptional mechanisms, whereas 48 h of RA treatment leads to down-regulation of both 4E-BP1 mRNA and protein. These results are in agreement with the effects we reported on 4E-BP1 and 4E-BP2 expression during RA-induced granulocytic differentiation of HL-60 cells. 11 In the two NB4 subclones resistant to the granulocytic differentiation induced by RA, we did not observe any modifiLeukemia cation of 4E-BP1 and 4E-BP2 protein expression. A mutation in the E domain of PML/RAR␣ is associated with NB4-R2. This mutation generates a truncated form of PML/RAR␣ which has lost 52 amino acids at its C-terminal end. The mutant exerts a dominant negative effect on wild-type PML, PML/RAR␣ and RAR␣ transcription activity. 18 It has also been recently reported that in NB4-R1 and NB4-R2 cells, the induction of the transcription factors, Stat1 and p48, by RA is completely blocked. 19, 20 However, the up-regulation of 4E-BP2 following RA treatment is not due to a transcriptional response of the 4E-BP2 gene as no induction of 4E-BP2 mRNA is observed. cAMP-dependent signal transduction co-operates with retinoids to induce acute promyelocytic leukemia (APL) cell maturation. NB4-R1 cells respond to RA but fail to mature unless the 'priming' signal is complemented by cAMP. 17, 21 Interestingly, in RA-primed NB4-R1 cells, a secondary event triggered by cAMP restored 4E-BP1 down-regulation, concomitant to maturation, but not 4E-BP2 induction. Therefore, even though 4E-BP2 up-regulation is a rapid event, preceding 4E-BP1 down-regulation, 4E-BP1 down-regulation is not a consequence of 4E-BP2 up-regulation and involves a different pathway. In addition, this indicates that 4E-BP1 down-regulation is specifically associated with cell maturation whereas post-transcriptional regulation of 4E-BP2 is associated with the early action of RA in cell maturation. This is of great interest as previous work revealed a complex pattern of subtle changes at the protein level distinguishing RA-sensitive and RA-resistant cells. For example, RAR␣ and PML-RAR␣ mRNA are not modulated by RA and/or cAMP, while significant changes were observed at the protein levels, most likely resulting from translational regulation. 22 Therefore, in addition to a general inhibition of protein synthesis, expression of 4E-BP1 or 4E-BP2 could confer different translational regulation of gene expression. It would be of great interest to determine the existence of specific genes whose translation may be regulated specifically or predominantly by 4E-BP1 or by 4E-BP2.
